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In the past two decades, the international health ef-
forts have been focused on the control of infectious 
diseases  in  developing  countries  with  non-
communicable diseases (NCDs) given a lower priori-
ty.
1  However,  the  incidence  of  NCDs  including 
chronic kidney disease (CKD) is increasing in devel-
oping countries where primary care intervention for 
CKD is often inadequate.
2 The main international fo-
cus  is  now  on  NCDs  including  diabetes  mellitus 
(DM), hypertension, obesity and chronic airway ob-
struction. Most of the NCDs share common risk fac-
tors  which  are  potentially  amenable  to  behavioral 
modifications  including  smoking,  unhealthy  diet, 
physical inactivity and stress. These diseases can usu-
ally be detected by simple tests which are available in 
primary care settings even in low and middle income 
countries. CKD which is often caused by underlying 
diseases such as DM and hypertension can be effec-
tively prevented by detection and treatment of these 
diseases.
2  According  to  Kidney  Disease  Outcomes 
Quality  Initiative  (KDOQI)  guidelines,  CKD  is  de-
fined as i) Persistent glomerular filtration rate (GFR) 
< 60 mL/min/1.73 m
2 for ≥ 3 months with or without 
kidney damage or ii) Kidney damage for ≥ 3 months 
based on structural and functional anomalies of the 
kidney with or without decreased GFR.
3  
CKD is now a common health problem globally; 
up to 10% of world’s population is estimated to suffer 
from CKD.
4  Number of the patients with end stage 
renal  disease  (ESRD)  keeps  increasing  and  is  now 
projected to affect more than 2 million people world-
wide.  Increasing  incidence  of  CKD  not  only  adds 
burden to global health care resources but also has 
significant  impact  on  patients  and  their  families. 
Therefore, it is of great importance to detect and pre-
vent CKD at its early stages.
5  
In 2004, over 700,000 patients were estimated to 
have  CKD  in  Iran  with  incidence  rate  of 
173.5/100,000. CKD was responsible for 1,145,654 
disability adjusted life years (DALYs).  Among the 
underlying causes for stages of 1 to 4 of CKD in Ira-
nian population, DM and hypertension were the most 
common  ones.  In  2008,  more  than  24,000  patients 
were  estimated  to  suffer  from  ESRD  (stage  5  of 
CKD) in Iran. Patients with ESRD constitute the tip 
of iceberg of patients with varying degrees of CKD.
6 
In  Iran,  the  annual  number  of  patients  with  ESRD 
beginning  maintenance  therapy  increased  by  130% 
between 2000 and 2006. The incidence of ESRD sec-
ondary to DM increased 2 folds from 1997 to 2006 
(from 16% to 31%).
7 
Patients with CKD are 5 to 11 times more likely to 
die prematurely than to progress to ESRD.
8 The high 
disease burden of CKD, the high cost of treatment 
and the fact that preventive measures are not yet fully 
in place in many countries, quantify CKD as a public 
health problem.
9 
The main risk factors for CKD are DM, hyperten-
sion, obesity, aging of the population, dyslipidemia, 
family  history  of  kidney  disease  and  smoking.
10 
Among these risk factors, DM is the leading cause of 
CKD globally; presently, diabetic nephropathy is es-
timated to affect 285 million adults worldwide. It is 
expected to rise by 54% to 839 million by 2030 ac-
cording  to  the  International  Diabetes  Federation.
11 
Increased prevalence of hypertension from 972 mil-
lion to 1.5 billion by 2015 is also expected.
12 
The screening and preventive strategies must be 
well suited to the particular population by considering Chronic kidney disease 
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the availability of human and material resources and 
require different approaches depending on the race, 
habitual and socioeconomic status.
5,10 By considering 
the complex interrelationship between CKD and pre-
ventable risk factors, a screening program for hyper-
tension, DM, obesity and proteinuria must occur at 
primary care level and preferentially be incorporated 
into  the  millennium  development  goals.  Although 
targeted screening has been advocated in high income 
countries in view of its cost-effectiveness, screening 
all of the population may be more suitable for less 
sophisticated  health  systems;  because  this  will  in-
crease detection rate and proper management of other 
NCDs as well as CKD.
13 Failure to detect CKD at its 
early stages can result in high morbidity and mortali-
ty; however, early detection of CKD is difficult be-
cause of its asymptomatic nature.
14  
Dipstick  urine  examination  at  least  for  high  risk 
groups and shared care program are cost-effective for 
CKD screening and prevention.
5 The cost-effectiveness 
and improved detection of NCDs has been proven in the 
Chennai Project in Southern India.
10 Screening for renal 
diseases by measuring blood pressure and using a single 
urinary dipstick test in Iranian school-age children was 
also demonstrated to be cost-effective.
15 Prevention of 
urinary tract infection as the leading cause of CKD in 
children with vesicoureteral reflux or obstruction of the 
urinary tract can be effective in prevention of CKD. 
Reducing the rate of hypertension, DM and its at-
tendant  cardiovascular  disease  will  involve  lifestyle 
modifications like weight reduction and a healthy diet 
including decrement in the consumption of saturated fat 
and synthetic foods and increment in consumption of 
fruits and vegetables, regular exercise, and cessation of 
smoking.
10  Decreasing  the  rate  of  prescription  of  ne-
phrotoxic medications also appears to be of great im-
portance.  
In patients with CKD, target blood pressure (BP) 
levels should be < 130/80 mmHg and a tighter BP con-
trol (<125/75 mmHg) is recommended in patients with 
DM or proteinuria > 1 gram/ 24 hours.
10 Angiotensin 
converting enzyme inhibitors and/or angiotensin recep-
tor blockers are the first choice medications for control 
of hypertension in patients with CKD and proteinuria. 
Furthermore, strict glycemic control (HbA1C < 7%) 
should be the goal in diabetic patients.
10 
Training of nephrologists and sustained education 
of general physicians and other health care personnel 
is  an  essential  part  of  development  of  preventive 
measures for CKD. Furthermore, sustained collabora-
tion  among  governmental  agencies,  health  policy 
makers, pharmaceutical industry, international socie-
ties and philanthropic bodies is necessary.
10 
On March 10, 2011, the sixth World Kidney Day 
will be celebrated. This annual event has been initiat-
ed  by  International  Society  of  Nephrology  and  
International  Federation  of  Kidney  Foundations  in 
order to raise the awareness of health care providers, 
government health officials and general public about 
kidney  diseases  and  their  attendant  complications. 
World Kidney Day activities will provide a very good 
opportunity to appreciate and robust the notion that 
kidney disease is common, preventable and treatable. 
The theme of this year’s world kidney day is “Protect 
your kidneys and Save your heart”.
16 CKD is an im-
portant and independent risk factor for premature car-
diovascular disease, the most important cause of mor-
tality and morbidity worldwide. Screening, early detec-
tion and treatment of kidney diseases not only improve 
the long-term renal but also cardiovascular outcomes.
16 
In summary, CKD and its underlying diseases are 
becoming a major health problem in developing coun-
tries. Screening for the risk factors of CKD and their 
proper management has a great role in prevention of 
CKD in children and adults. This demands collabora-
tion between health policy makers and governmental 
agencies, educated healthcare staff, sufficient financial 
support and extensive public education. 
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